ストックスクリーナーアプリを入手
3.83
3.28%
-0.13
アフターアワーズ：
3.95
0.12
+3.13%
Annexon Inc (ANNX) 最新ニュース
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance Australia
Insider Spends US$100k Buying More Shares In Annexon - simplywall.st
After buying shares at a $3.83 average, Annexon (ANNX) CEO Love Douglas holds 390,476 shares. - Stock Titan
Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting - Investing News Network
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Annexon at Cantor Fitzgerald conference: eye data, gbs progress By Investing.com - Investing.com Nigeria
Annexon at Cantor Fitzgerald conference: eye data, gbs progress By Investing.com - Investing.com South Africa
ANNX: Vonaprument's phase III trial in GA shows promise for vision preservation and broad market impact - TradingView
ANNX: Phase III GA study shows strong vision preservation, with high compliance and dual primary endpoints - TradingView
Annexon at Cantor Fitzgerald conference: eye data, gbs progress By Investing.com - Investing.com UK
ANNX: Phase III programs in GBS and GA advance toward key data and regulatory milestones, with strong differentiation - TradingView
Annexon at Wells Fargo 21st annual healthcare conference: late-stage push - Investing.com India
Annexon at Wells Fargo 21st annual healthcare conference: late-stage push - Investing.com
Annexon at Wells Fargo 21st annual healthcare conference: late-stage push - Investing.com Canada
Annexon at Wells Fargo 21st annual healthcare conference: late-stage push - Investing.com UK
Annexon to Participate in Upcoming September Investor Conferences - Investing News Network
Annexon to Participate in Upcoming September Investor Conferences - finance.yahoo.com
ANNX Maintained by JP Morgan -- Price Target Raised to $14.00 - GuruFocus
ANNEXON, INC. : JP MORGAN RAISES TARGET PRICE TO $14 FROM $10 - Moomoo
ANNEXON, INC. : JP MORGAN RAISES TARGET PRICE TO $14 FROM $10 - Bitget
What Annexon (ANNX)'s Dual-Endpoint ARCHER II Update Means For Shareholders - Yahoo Finance
Annexon (ANNX): Pipeline Momentum Is Building, but Cash Discipline Still Runs the Story - AlphaStreet
Annexon (ANNX) Quarterly Figures: The Available Earnings Metric Delivers a Beat in the Current Update; Share Response: The Stock Loses 4.55% in the Current UpdateMargin Guidance - vinanet.vn
Annexon (ANNX) Quarterly Figures: The Available Earnings Metric Delivers a Beat in the Current Update; Share Response: The Stock Loses 4.55% in the Current UpdateOne-Time Gain Impact - dars.gov.et
Annexon (ANNX) Q2 2026 Earnings Call Transcript - AOL.com
Annexon, Inc. Stock 12‑Month Price Target Raised to $15.71, Implies 198% Upside - TradingView
Annexon (ANNX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Annexon Reports Inducement Grants to New Employees under Nasdaq Listing Rule 5635(4) - marketscreener.com
Bank of America Corp DE Has $23.60 Million Stock Holdings in Annexon, Inc. $ANNX - MarketBeat
Annexon Inc (ANNX) Stock News Today - TradingKey
Annexon Inc (ANNX) Stock News Today - TradingKey
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
At $5.29, Annexon grants new employees options vesting over four years - Stock Titan
Annexon (ANNX) Adds Dual Primary Endpoint in Phase 3 Trial, Refl - GuruFocus
Annexon (ANNX) Earnings Call zu Q2 2026: ARCHER II erweitert, BLA-Einreichung im Zeitplan - TradingKey
Annexon (ANNX) Q2 2026 Earnings Call: ARCHER II Expanded, BLA Filing on Track - TradingKey
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - Barchart.com
What is HC Wainwright's Estimate for Annexon Q3 Earnings? - MarketBeat
Annexon (ANNX) Is Down 6.1% After Dual Endpoint Shift in ARCHER II TrialWhat's Changed - Sahm
Annexon (NASDAQ:ANNX) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat
ANNX SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Annexon (ANNX) Is Down 6.1% After Dual Endpoint Shift in ARCHER II TrialWhat's Changed - webull.com
State Street Corp Boosts Annexon Inc (ANNX) Stake by 42% in June Transaction - GuruFocus
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $8 to $27 - Moomoo
Insider for ANNX (ANNX) plans sale of 2,000 shares after option exercise - Stock Titan
Annexon (ANNX), What Is Behind Its Latest Update? - Yahoo Finance
ANNX Upgraded by Citizens -- Rating Changed to Market Perform - GuruFocus
Annexon (NASDAQ:ANNX) Upgraded at Citizens Jmp - MarketBeat
BofA Securities Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Citizens upgrades Annexon stock rating on trial endpoint changes - Investing.com
0.85%
大文字化:
|
ボリューム (24 時間):